	Unnamed: 0	Sample.ID	sex	Age	Sequencing	sample_ID	Institution	Manuscript.ID	Dx	DxELN_Cytogenetic	Cytogenetics	Overall.survival	Flow.report.summary	RAS.pathway	NPM1	IDH	TET2	TP53	RUNX1	CBF	MLL.rearranged	IDH1	IDH2	ASXL1	BCOR	CBL	CEBPAdm	CSF3R	DNMT3A	ETV6	FLT3.TKD	FLT3.ITD	GATA2	JAK2	KIT	NPM1.1	NRAS	KRAS	PTPN11	PHF6	RAD21	RUNX1.1	SETBP1	SMC1A	STAG2	SRSF2	SF3B1	TET2.1	U2AF1	WT1	TP53.1	ZRSR2	health_status	case_or_control	nr_cells_raw	nr_cells_cf	nr_cells_cf_ctf	total_counts_raw_cf_ctf_gf	nr_celltypes_cf_ctf_gf	threshold_nr_celltypes	passed_threshold_nr_celltypes
6	6	U-18-4340	M	80	CITE-seq	AML-4340	OSU	AML4340	AML	Intermediate	46,XY	455.0	"Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 56.7 % of the total events 
analyzed. Of the lymphocytes: 73.2 % are T cells (CD3+) with a 
CD4:CD8 ratio of 2.3 and 12.0 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). The B cells represent 13.5 % 
of the lymphocytes (8.0 % of the total events analyzed) and 
express CD19+, CD20+ bright Â with subpopulation(s) expressing 
CD23+(4%). The B cells are essentially negative for CD10 and 
CD5. Surface immunoglobulin light chains shows a Kappa:Lambda 
ratio of 13:2 with bright staining intensity. Blasts, defined by CD45 
faint staining and low side scatter represent 19.6 % of the total 
events analyzed and express HLA-DR+, CD13+, CD33+, CD34+, 
CD117+, and are negative for the remaining markers analyzed. "	x		x						0,37	0	0	0	0.0	0.0	0,34	0	0.0	0	0.0	0.0	0.0	0.0	0	0.0	0,24	0	0.0	0.0	0	0.0	0.0	0.0	0	0.0	0	0	0.0	0	0.0	AML	case	2800	2793	2787	6733115.22728632	7	greater or equal 7	True
4	4	U-16-2123	F	71	CITE-seq	AML-2123	OSU	AML2123	AML	Intermediate	46,XX	1807.0	"Immunophenotypic analysis demonstrates an abnormal myeloid 
HLA-DR+CD13+CD33+CD34+MPO(var)+ myeloblast population, 
consistent with acute myeloid leukemia. Correlation with bone 
marrow morphology and cytogenetic studies is recommended. 
PHENOTYPIC DESCRIPTION: Flow cytometric analysis of bone 
marrow was performed using a ten color technique with a gating 
strategy based on CD45 staining and light side scatter 
characteristics. Lymphocytes represent 23.0 % of the total events 
analyzed. Of the lymphocytes: 7.0 % are B cells (CD19+) with a 
Kappa:Lambda ratio of 3:2 , 88.0 % are T cells (CD3+) with a 
CD4:CD8 ratio of 1.9 and 5.6 % are NK cells (positive for CD56 
and/or CD16 and negative for CD3). Blasts, defined by CD45 faint 
staining and low side scatter represent 44.4 % of the total events 
analyzed and express HLA-DR+, CD13+, CD33+, CD34+ with 
subpopulation(s) expressing cMPO+ ( 44%) and are negative for 
the remaining markers analyzed. "			x						0,25	0	0	0	0.0	0.0	0	0	0.0	0	0.0	0.0	0.0	0.0	0	0.0	0	0	0.0	0.0	0	0.0	0.0	0.0	0							AML	case	1333	1278	1265	2819869.57993261	7	greater or equal 7	True
0	0	U-06-0024	M	64	CITE-seq	AML-0024	OSU	AML0024	AML	Adverse	48,XY,+8,+8,i(8)(p10),t(9;15)(q33;q15),del(10)(q22.1q24),del(13)(q14q21)	137.0										0+T2:BL24	0,46	0	0,99	0.0	0.0	0	0	0.0	0,06	0.0	0.0	0.0	0.0	0,17	0.0	0	0,17	0.0	0.0	0	0.0	0.0	0.0	0	0.0	0	0,45	0.0	0	0.0	AML	case	6141	6127	6127	16080180.1293001	8	greater or equal 7	True
9	9	3	F	50	CITE-Seq	healthy-3																																															healthy	control	4008	3986	3963	8805479.48941174	8	greater or equal 7	True
8	8	2	M	39	CITE-Seq	healthy-2																																															healthy	control	2489	2476	2399	5431881.0778559	8	greater or equal 7	True
11	11	4003	M	42	CITE-Seq + scTCR-seq	healthy-4003																																															healthy	control	6890	6802	6783	14441581.3459165	8	greater or equal 7	True
